- Enhanced radial introducer sheaths feature superior sheath-to-dilator transition and extended hydrophilic coating for smooth radial access
- 17 models and three kit configurations designed to meet the needs of a variety of radial access techniques
- Radial access remains one of the fastest-growing cardiac cath lab practice trends in the U.S.
MINNEAPOLIS, Jan. 25, 2016 -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced the launch in the United States of its enhanced line of VSI Radial introducer sheaths for use in the introduction of guidewires and catheters into veins and arteries. The VSI Radial introducer sheaths are specifically designed for patients undergoing transradial catheterization procedures, one of the fastest-growing practices in the field of interventional cardiology in the U.S.
The new versions of the VSI Radial introducer sheaths enhance the original versions that were launched in early 2015. The new versions feature a superior sheath-to-dilator transition and an extended hydrophilic coating that includes both the sheath and the dilator. In addition, an angled tip wire has been added to the options.
“Vascular Solutions is committed to providing a complete range of specialized devices for radial artery catheterization procedures, and therefore we are excited by the availability of our new introducer sheaths,” said Howard Root, CEO of Vascular Solutions. “Radial access procedures represented fewer than 2% of all cardiac catheterization procedures in the U.S. just seven years ago. Today, we believe radial access is used in approximately 25% of cath lab procedures. Yet, we expect this percentage to continue to grow over the next several years, and Vascular Solutions is well-positioned to contribute to and benefit from this major trend in U.S. interventional practice.”
Vascular Solutions now offers 17 models of the VSI Radial introducer sheaths. The sheaths are available in 4F, 5F, and 6F diameters and in 7cm, 11cm, and 24cm lengths. Three kit configurations are available to accommodate a variety of radial access techniques: standard kits designed for the single-wall micro-puncture technique, access kits designed for the double-wall micro-puncture technique, and 0.035” kits designed for converting a 4F or 5F diagnostic procedure into a 6F intervention.
About Vascular Solutions
Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company’s product line consists of more than 90 products and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists, and vein specialists through its direct U.S. sales force and international independent distributor network.
The information in this press release contains forward-looking statements about Vascular Solutions that involve risks and uncertainties. Vascular Solutions’ actual results could differ materially from those anticipated in these forward-looking statements. Important factors that may cause such differences include those discussed in the company Annual Report on Form 10-K for the year ended December 31, 2015 and other recent filings with the Securities and Exchange Commission. The risks and uncertainties include, without limitation, risks associated with the need for adoption of the company’s new products, defense of criminal litigation, exposure to potential shareholder litigation, exposure to intellectual property claims and litigation, significant variability in quarterly results, exposure to possible product liability claims, doing business in international markets, the development of new products by others, the company’s reliance on the development of new products and services, constraints or interruptions in production from key suppliers, breaches or other failures of information technology and communications systems, the availability of third party reimbursement, and actions by government regulatory agencies.
For further information, connect to www.vasc.com.
Contact: Vascular Solutions, Inc. Phil Nalbone, VP-Corp. Dev. [email protected] (763) 656-4371


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Instagram Outage Disrupts Thousands of U.S. Users
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



